132 related articles for article (PubMed ID: 17416392)
1. Determination of the optimal therapeutic protocols in cancer immunotherapy.
Cappuccio A; Castiglione F; Piccoli B
Math Biosci; 2007 Sep; 209(1):1-13. PubMed ID: 17416392
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy, mathematical modeling and optimal control.
Castiglione F; Piccoli B
J Theor Biol; 2007 Aug; 247(4):723-32. PubMed ID: 17543345
[TBL] [Abstract][Full Text] [Related]
3. Tumour suppression by immune system through stochastic oscillations.
Caravagna G; d'Onofrio A; Milazzo P; Barbuti R
J Theor Biol; 2010 Aug; 265(3):336-45. PubMed ID: 20580640
[TBL] [Abstract][Full Text] [Related]
4. Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function.
Engelhart M; Lebiedz D; Sager S
Math Biosci; 2011 Jan; 229(1):123-34. PubMed ID: 21129386
[TBL] [Abstract][Full Text] [Related]
5. Optimal control in a model of dendritic cell transfection cancer immunotherapy.
Castiglione F; Piccoli B
Bull Math Biol; 2006 Feb; 68(2):255-74. PubMed ID: 16794930
[TBL] [Abstract][Full Text] [Related]
6. Optimization of interleukin-21 immunotherapeutic strategies.
Cappuccio A; Elishmereni M; Agur Z
J Theor Biol; 2007 Sep; 248(2):259-66. PubMed ID: 17574601
[TBL] [Abstract][Full Text] [Related]
7. Optimal therapeutic protocols in cancer immunotherapy.
Ghaffari A; Naserifar N
Comput Biol Med; 2010 Mar; 40(3):261-70. PubMed ID: 20045103
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy in radical surgery of colorectal carcinoma].
Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
[TBL] [Abstract][Full Text] [Related]
9. Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy.
Kiran KL; Lakshminarayanan S
Biosystems; 2010 Aug; 101(2):117-26. PubMed ID: 20639123
[TBL] [Abstract][Full Text] [Related]
10. [Dosage regimen optimization in cancer chemotherapy using a mathematical model].
Barbolosi D; Freyer G; Ciccolini J; Iliadis A
Bull Cancer; 2003 Feb; 90(2):167-75. PubMed ID: 12660135
[TBL] [Abstract][Full Text] [Related]
11. Cancer immunotherapy.
Baxevanis CN; Perez SA; Papamichail M
Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
[TBL] [Abstract][Full Text] [Related]
12. Rational interleukin-2 therapy.
Smith KA
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S137-40. PubMed ID: 9457409
[TBL] [Abstract][Full Text] [Related]
13. Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes.
Chareyron S; Alamir M
J Theor Biol; 2009 Jun; 258(3):444-54. PubMed ID: 18655792
[TBL] [Abstract][Full Text] [Related]
14. Optimization of HAART with genetic algorithms and agent-based models of HIV infection.
Castiglione F; Pappalardo F; Bernaschi M; Motta S
Bioinformatics; 2007 Dec; 23(24):3350-5. PubMed ID: 17942443
[TBL] [Abstract][Full Text] [Related]
15. A new optimization based approach to experimental combination chemotherapy.
Pereira FL; Pedreira CE; de Sousa JB
Front Med Biol Eng; 1995; 6(4):257-68. PubMed ID: 7612501
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma.
Donskov F
Dan Med Bull; 2007 Nov; 54(4):249-65. PubMed ID: 18208677
[TBL] [Abstract][Full Text] [Related]
17. MR guided cancer treatment system for an elevated therapeutic index - a macroscopic approach.
Myhr G
Med Hypotheses; 2008; 70(3):665-70. PubMed ID: 17765401
[TBL] [Abstract][Full Text] [Related]
18. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapies to improve tumor immunotherapy.
Begley J; Ribas A
Clin Cancer Res; 2008 Jul; 14(14):4385-91. PubMed ID: 18628452
[TBL] [Abstract][Full Text] [Related]
20. Dynamic response of cancer under the influence of immunological activity and therapy.
de Vladar HP; González JA
J Theor Biol; 2004 Apr; 227(3):335-48. PubMed ID: 15019501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
